TG Therapeutics
TGTX
TGTX
303 hedge funds and large institutions have $2.36B invested in TG Therapeutics in 2024 Q3 according to their latest regulatory filings, with 96 funds opening new positions, 93 increasing their positions, 72 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
303
Holders Change
+49
Holders Change %
+19.29%
% of All Funds
4.38%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
96
Increased
93
Reduced
72
Closed
44
Calls
$70.9M
Puts
$46.8M
Net Calls
+$24.2M
Net Calls Change
+$10.5M
Top Buyers
| 1 |
BlackRock
New York
|
+$247M |
| 2 |
State Street
Boston,
Massachusetts
|
+$56.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.7M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$26.8M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$17M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$40.6M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$36.5M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$35.1M |
| 4 |
Millennium Management
New York
|
-$33.8M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$26.8M |
